Cargando…
Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy
We investigated long-term treatment responses in patients with treatment-naïve polypoidal choroidal vasculopathy (PCV) undergoing photodynamic therapy (PDT) with intravitreal ranibizumab (IVR). The medical charts of 14 patients with treatment-naïve PCV who underwent PDT with IVR were retrospectively...
Autores principales: | Azuma, Keiko, Okubo, Atsushi, Nomura, Yoko, Zhou, Hanpeng, Terao, Ryo, Hashimoto, Yohei, Asano, Kimiko Shimizu, Azuma, Kunihiro, Inoue, Tatsuya, Obata, Ryo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239911/ https://www.ncbi.nlm.nih.gov/pubmed/32433551 http://dx.doi.org/10.1038/s41598-020-65346-w |
Ejemplares similares
-
Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy
por: Asano, Shotaro, et al.
Publicado: (2018) -
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
por: Sonoda, Shozo, et al.
Publicado: (2013) -
Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
por: Azuma, Keiko, et al.
Publicado: (2018) -
Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy
por: Yamashiro, Kenji, et al.
Publicado: (2022) -
Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
por: Miura, Masahiro, et al.
Publicado: (2013)